Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data Full Text
BMC Psychiatry,  Clinical Article

Detke HC et al. – Patients treated acutely with olanzapine long–acting injection (LAI) showed a similar pattern of improvement to that seen historically with oral olanzapine. With the exception of injection–related adverse events, the efficacy and tolerability profile of olanzapine LAI is similar to oral olanzapine.

Methods
  • Six-week results from the olanzapine LAI study (N=404) were compared with those of 3 oral studies (study 1: olanzapine vs. haloperidol vs. placebo [N=335]; study 2: olanzapine vs. haloperidol vs. low-dose olanzapine [N=431]; study 3: olanzapine vs. placebo vs. low-dose olanzapine [N=152]).
  • All patients had baseline Brief Psychiatric Rating Scale (BPRS) scores >=24 (0-6 scale).
  • Six-week effect sizes were calculated.
  • Efficacy onset, pharmacokinetics, discontinuations, weight gain, and extrapyramidal symptoms were also assessed.

Results
  • At 6 weeks, mean BPRS scores decreased by 14 to 15 points for olanzapine LAI (405 mg/4 weeks, 210 or 300 mg/2 weeks), by 8 to 16 for oral olanzapine (10+/-2.5 or 15+/-2.5 mg/day), and by 12 to 13 for haloperidol (15+/-5 mg/day).
  • For those same dose groups, effect sizes vs. placebo for the BPRS were 0.7 to 0.8 for olanzapine LAI, 0.5 to 0.7 for oral olanzapine, and 0.6 for haloperidol.
  • The first statistically significant separation from placebo on the BPRS occurred at 3 days for the olanzapine LAI groups and at 1 week for oral olanzapine and haloperidol (15+/-5 mg/day) in oral study 1 although as late as week 6 for the 10-mg/day olanzapine dose in oral study 3.
  • Olanzapine concentrations were similar across studies.
  • Weight gain >=7% of baseline occurred in up to 35% of olanzapine LAI and oral patients versus up to 12% of haloperidol and placebo patients.
  • Extrapyramidal symptoms were lowest in the olanzapine LAI groups and significantly greater in the haloperidol groups.
  • No post-injection delirium/sedation syndrome events occurred in the olanzapine LAI study.

Please login or register to follow this author.
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Psychiatry

See All >> Messages include industry-sponsored communications and special communications from MDLinx

<

Most Popular Psychiatry Articles

1 Prophylactic efficacy of fluoxetine, escitalopram, sertraline, paroxetine, and concomitant psychotherapy in major depressive disorder: Outcome after long-term follow-up Psychiatry Research, December 3, 2014    Clinical Article

2 Are antidepressants equally effective in the long-term treatment of major depressive disorder? Human Psychopharmacology: Clinical and Experimental, December 8, 2014    Clinical Article

3 Safety and tolerability of atomoxetine in treatment of attention deficit hyperactivity disorder in adult patients: An integrated analysis of 15 clinical trials Journal of Psychopharmacology, December 2, 2014    Clinical Article

4 Venlafaxine versus applied relaxation for generalized anxiety disorder: A randomized controlled study on clinical and electrophysiological outcomes Psychiatric Quarterly, December 19, 2014    Clinical Article

5 Nitrous oxide for treatment-resistant major depression: A proof-of-concept trial Biological Psychiatry, December 24, 2014    Clinical Article

6 Weight gain and associated factors in patients using newer antidepressant drugs General Hospital Psychiatry, December 4, 2014    Clinical Article

7 Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: A randomized, double-blind, placebo-controlled trial International Clinical Psychopharmacology, December 23, 2014    Clinical Article

8 Zolpidem and the risk of Parkinson's disease: A nationwide population-based study Journal of Psychiatric Research, August 1, 2014    Clinical Article

9 Rational-emotive and cognitive-behavior therapy (REBT/CBT) versus pharmacotherapy versus REBT/CBT plus pharmacotherapy in the treatment of major depressive disorder in youth: A randomized clinical trial Psychiatry Research, December 15, 2014    Clinical Article

10 Theta-burst stimulation: A new form of TMS treatment for depression? Depression and Anxiety, December 22, 2014    Clinical Article

11 The impact of telephone versus e-mail therapist guidance on treatment outcomes, therapeutic alliance and treatment engagement in Internet-delivered CBT for depression: A randomised pilot trial Internet Interventions, December 12, 2014    Clinical Article

12 Maternal thyroid autoantibody and elevated risk of autism in a national birth cohort Progress in Neuro-Psychopharmacology and Biological Psychiatry, December 1, 2014    Clinical Article

13 Living SMART — A randomized controlled trial of a guided online course teaching adults with ADHD or sub-clinical ADHD to use smartphones to structure their everyday life Internet Interventions, December 5, 2014    Clinical Article

14 Antipsychotic treatment and mortality in schizophrenia Schizophrenia Bulletin, December 16, 2014    Clinical Article

15 Blood manganese levels in relation to comorbid behavioral and emotional problems in children with attention-deficit/hyperactivity disorder Psychiatry Research, November 4, 2014    Clinical Article

16 Aripiprazole versus quetiapine in treatment-resistant obsessive–compulsive disorder: A double-blind clinical trial Therapeutic Advances in Psychopharmacology, December 24, 2014    Clinical Article
Exclusive Author Commentary

17 Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: A systematic review and meta-analysis of randomized clinical trials JAMA Psychiatry, October 22, 2014    Evidence Based Medicine    Clinical Article

18 Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder JAMA Psychiatry, December 11, 2014    Evidence Based Medicine    Clinical Article

19 Cognitive effects of statin medications CNS Drugs, February 18, 2014    Clinical Article

20 Low serum levels of vitamin D are associated with post-stroke depression European Journal of Neurology, December 9, 2014    Clinical Article

Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addictionmore

Make smarter career moves with less time.

Sign up for our free job placement service today and have a dedicated career consultant help locate the right physician job for you!
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.
 

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List